Profil
Schond L.
Greenway worked at Halozyme Therapeutics, Inc. as Executive Director-Strategy & IR from 2013 to 2016.
Worked at Mesoblast Ltd. as VP & Global Head-Investor Relations from 2016 to 2021.
Worked at Avalo Therapeutics, Inc. as Chief Financial Officer & Treasurer from 2021 to 2022.
Worked at Definium Therapeutics, Inc. as Chief Financial Officer from 2022 to 2024.
Also held positions at DURECT Corp.
as VP-Investor Relations & Strategic Planning and at Barclays Capital, Inc. as Vice President-Healthcare.
Education includes undergraduate studies at Florida A&M University and an MBA from the University of Virginia Darden School of Business.
Anciens postes connus de Schond Greenway
| Sociétés | Poste | Fin |
|---|---|---|
| DEFINIUM THERAPEUTICS, INC. | Directeur Financier/CFO | 03/05/2024 |
| AVALO THERAPEUTICS, INC. | Directeur Financier/CFO | 14/02/2022 |
| MESOBLAST LIMITED | Investor Relations Contact | 01/02/2021 |
| HALOZYME THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2016 |
| DURECT | Public Communications Contact | - |
Formation de Schond Greenway
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
DURECT Corp.
DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Florida A&M University
Florida A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mind Medicine (MindMed), Inc.
Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
















